Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
49.9M
-
Number of holders
-
54
-
Total 13F shares, excl. options
-
25.4M
-
Shares change
-
-993K
-
Total reported value, excl. options
-
$437M
-
Value change
-
-$15.4M
-
Number of buys
-
34
-
Number of sells
-
-20
-
Price
-
$17.19
Significant Holders of HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) as of Q2 2023
65 filings reported holding HLVX - HilleVax, Inc. - Common Stock, par value $0.0001 per share as of Q2 2023.
HilleVax, Inc. - Common Stock, par value $0.0001 per share (HLVX) has 54 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.4M shares
of 49.9M outstanding shares and own 50.95% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (9.78M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.33M shares), Carlyle Group Inc. (1.84M shares), T. Rowe Price Investment Management, Inc. (1.42M shares), FRANKLIN RESOURCES INC (1.28M shares), BlackRock Inc. (1.27M shares), BRAIDWELL LP (1.25M shares), VANGUARD GROUP INC (904K shares), StepStone Group LP (677K shares), and Samsara BioCapital, LLC (599K shares).
This table shows the top 54 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.